Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities

Diabetes

Volumn 61, Issue 5, 2012, Pages 1234-1242

  Carvalho, Cristina ^a,b   Cardoso, Susana ^a,b   Correia, Sónia C ^a,b   Santos, Renato X ^a,b   Santos, Maria S ^a,b   Baldeiras, Inês ^a,c   Oliveira, Catarina R ^a,d   Moreira, Paula I ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; CALCIUM; DRINKING WATER; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; SUCROSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BRAIN MITOCHONDRION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEMBRANE DEPOLARIZATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; POLAROGRAPHY; PRIORITY JOURNAL; REPOLARIZATION; RESPIRATORY CHAIN; SPECTROPHOTOMETRY; SUGAR INTAKE; ULTRASTRUCTURE; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BRAIN; CALCIUM; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ELECTRON TRANSPORT; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GLUTATHIONE; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; OXIDATIVE STRESS; PHOSPHORYLATION; RANDOM ALLOCATION; SUCROSE; VITAMIN E;

EID: 84860599622     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1186     Document Type: Article

References (50)

1. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42: 1097-1105 (Pubitemid 16236926)
2. Kalaria RN, Maestre GE, Arizaga R, et al.; World Federation of Neurology Dementia Research Group. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008;7:812-826
3. Roriz-Filho JS, Sá-Roriz TM, Rosset I, et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009;1792:432-443
4. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997;275:630-631 (Pubitemid 27061322)
5. Moreira PI, Santos MS, Moreno AM, Seiça R, Oliveira CR. Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure. Diabetes 2003;52:1449-1456 (Pubitemid 36666200)
6. Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta 2010;1802:2-10
7. Correia SC, Carvalho C, Cardoso S, et al. Mitochondrial preconditioning: a potential neuroprotective strategy. Front Aging Neurosci 2010;2:138-150
8. Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759-767 (Pubitemid 32678256)
9. Cao D, Lu H, Lewis TL, Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 2007;282: 36275-36282
10. Estabrook RE. Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Methods Enzymol 1967;10:41-47
11. Kamo N, Muratsugu M, Hongoh R, Kobatake Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Membr Biol 1979;49:105-121 (Pubitemid 10221193)
12. Moreno AJM, Madeira VMC. Mitochondrial bioenergetics as affected by DDT. Biochim Biophys Acta 1991;1060:166-174
13. Krebs HA, Holzach O. The conversion of citrate into cis-aconitate and isocitrate in the presence of aconitase. Biochem J 1952;52:527-528
14. Barja G. Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J Bioenerg Biomembr 1999;31:347-366 (Pubitemid 30058570)
15. Hissin PJ, Hilf RA. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-226
16. Vatassery GT, Younoszai R. Alpha tocopherol levels in various regions of the central nervous systems of the rat and guinea pig. Lipids 1978;13:828-831 (Pubitemid 9080573)
17. Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114-121 (Pubitemid 14165378)
18. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985; 113:484-490 (Pubitemid 16195819)
19. Flohé L, Otting F. Superoxide dismutase assays. Methods Enzymol 1984; 105:93-104 (Pubitemid 14165376)
20. Wuarin L, Namdev R, Burns JG, Fei ZJ, Ishii DN. Brain insulin-like growth factor-II mRNA content is reduced in insulin-dependent and non-insulin- dependent diabetes mellitus. J Neurochem 1996;67:742-751 (Pubitemid 26255672)
21. Hsueh WA, Orloski L, Wyne K. Prediabetes: the importance of early identification and intervention. Postgrad Med 2010;122:129-143
22. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004;63:1187-1192 (Pubitemid 39350015)
23. Kume K, Hanyu H, Sato T, et al. Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. J Neurol 2011;258:1295-1303
24. Magierski R, Kłoszewska I, Sobów TM. The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease. Neurol Neurochir Pol 2010;44:139-147
25. Makita Z, Vlassara H, Rayfield E, et al. Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 1992;258:651-653
26. Carvalho C, Correia SC, Santos RX, et al. Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia. J Bioenerg Biomembr 2009;41:433-440
27. Guyonnet S, Nourhashemi F, Andrieu S. A prospective study in the nutritional status of Alzheimer's patients. Arch Gerontol Geriatr 1998;6:255-262
28. Power DA, Noel J, Collins R, O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement Geriatr Cogn Disord 2001;12: 167-170 (Pubitemid 32149724)
29. Dragicevic N, Mamcarz M, Zhu Y, et al. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimers Dis 2010;20(Suppl. 2):S535-S550
30. Cardoso SM, Proença MT, Santos S, Santana I, Oliveira CR. Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 2004;25:105-110 (Pubitemid 37522198)
31. Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 2006; 545:39-50 (Pubitemid 44215876)
32. Bernardi P, Broekemeier KM, Pfeiffer DR. Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane. J Bioenerg Biomembr 1994;26: 509-517 (Pubitemid 24378753)
33. Carvalho C, Correia S, Santos MS, Seiça R, Oliveira CR, Moreira PI. Metformin promotes isolated rat liver mitochondria impairment. Mol Cell Biochem 2008;308:75-83 (Pubitemid 351167847)
34. Fontaine E, Eriksson O, Ichas F, Bernardi P. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complex i. J Biol Chem 1998;273:12662-12668 (Pubitemid 28240645)
35. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci USA 2010;107:18670-18675
36. Alberdi E, Sánchez-Gómez MV, Cavaliere F, et al. Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 2010;47:264-272
37. Kowaltowski AJ, Castilho RF, Vercesi AE. Mitochondrial permeability transition and oxidative stress. FEBS Lett 2001;495:12-15 (Pubitemid 32367965)
38. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006;15:1437-1449
39. Gardner PR, Raineri I, Epstein LB, White CW. Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem 1995;270:13399-13405
40. Vasquez-Vivar J, Kalyanaraman B, Kennedy MC. Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J Biol Chem 2000;275:14064-14069 (Pubitemid 30339680)
41. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO. Requirement for superoxide in excitotoxic cell death. Neuron 1996;16:345-355 (Pubitemid 26072367)
42. Durmaz A, Dikmen N. Homocysteine effects on cellular glutathione peroxidase (GPx-1) activity under in vitro conditions. J Enzyme Inhib Med Chem 2007;22:733-738 (Pubitemid 350215079)
43. Rauscher FM, Sanders RA, Watkins JB 3rd. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001;15:159-164 (Pubitemid 32514750)
44. Liu H, Wang H, Shenvi S, Hagen TM, Liu RM. Glutathione metabolism during aging and in Alzheimer disease. Ann N Y Acad Sci 2004;1019:346-349 (Pubitemid 38951332)
45. Mastrocola R, Restivo F, Vercellinatto I, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol 2005;187:37-44 (Pubitemid 41556399)
46. Resende R, Moreira PI, Proença T, et al. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008; 44:2051-2057
47. Peerapatdit T, Patchanans N, Likidlilid A, Poldee S, Sriratanasathavorn C. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients. J Med Assoc Thai 2006;89(Suppl. 5):S147-S155 (Pubitemid 46193144)
48. Baldeiras I, Santana I, Proença MT, et al. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. J Alzheimers Dis 2008;15:117-128
49. Zemlan FP, Thienhaus OJ, Bosmann HB. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Res 1989;476:160-162 (Pubitemid 19006378)
50. Li ZG, Zhang W, Sima AA. Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 2007;56:1817-1824 (Pubitemid 47025451)